Chongqing Lummy Pharmaceutical (SZSE:300006) GF Value : ¥3.14 (As of Jun. 27, 2025)

View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical GF Value?

As of today (2025-06-27), Chongqing Lummy Pharmaceutical's share price is ¥3.73. Chongqing Lummy Pharmaceutical's GF Value is ¥3.14. Therefore, Chongqing Lummy Pharmaceutical's Price-to-GF-Value for today is 1.19. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Chongqing Lummy Pharmaceutical is Modestly Overvalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Chongqing Lummy Pharmaceutical (SZSE:300006) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (1)
Possible Value Trap, Think Twice	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)	Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.

Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.

Chongqing Lummy Pharmaceutical's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	3.73	/	3.14
	=	1.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Lummy Pharmaceutical GF Value Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Lummy Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Yuma Road, Nan'an District, chongqing, CHN, 401123

Website

http://www.cqlummy.com

Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.

Executives

Lai Wen	Executives
Yuan Yuan	Supervisors
Qiu Yu	Directors, executives
Leng Xue Feng	Secretary, Director
Zhang Xiao Xue	Supervisors
Wang Ying	Director
Zhou Xue Mei	Supervisors
Zhao Bin	Executives
Tang Xiao Hai	Executives
Fu Rong	Executives
Li Xian Feng	Supervisors
Qiu Wei	Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines